Jacy Gameiro

Prof. Dr. Jacy Gameiro

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in Cell Adhesion & Migration
Verified
Journal Article
Closed access
JGJacy Gameiro
Jacy Gameiro
PNPatrícia Nagib
Patrícia Nagib
LVLIANA VERINAUD
LIANA VERINAUD
The thymus plays a crucial role in the development of T lymphocytes providing an inductive microenvironment in which committed progenitors undergo proliferation, T-cell receptor gene rearrangements and thymocyte differentiation into mature T-cells. The thymus microenvironment forms a complex network of interaction that comprises non lymphoid cells (e.g., thymic epithelial cells, TEC), cytokines, chemokines, extracellular matrix elements (ECM), matrix metalloproteinases and other soluble proteins. The thymic epithelial meshwork is the major component of thymic microenvironment, both morphologically and phenotypically limiting heterogeneous regions in thymic lobules and fulfilling an important role during specific stages of T-cell maturation. The process starts when bone marrow–derived lymphocyte precursors arrive at the outer cortical region of the thymic gland and begin to mature into functional T lymphocytes that will finally exit the thymus and populate the peripheral lymphoid organs. During their journ...

14 December 2019 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
FSFlávia Márcia de Castro e Silva
Flávia Márcia de Castro e Silva
EOErick Esteves de Oliveira
Erick Esteves de Oliveira
MAMarcilene Gomes Evangelista Ambrósio
Marcilene Gomes Evangelista Ambrósio
MAMarina Caçador Ayupe
Marina Caçador Ayupe
VSViviane Passos de Souza
Viviane Passos de Souza
AFAna Paula Ferreira
Ana Paula Ferreira

17 March 2021 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
FAFernanda B. Andrade
Fernanda B. Andrade
AGAna Gualberto
Ana Gualberto
CRCamila Rezende
Camila Rezende
NPNathércia Percegoni
Nathércia Percegoni
JGJacy Gameiro
Jacy Gameiro
EHEugenio DAMACENO Hottz
Eugenio DAMACENO Hottz
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged in December 2019 and rapidly outspread worldwide endangering human health. The coronavirus disease 2019 (COVID-19) manifests itself through a wide spectrum of symptoms that can evolve to severe presentations as pneumonia and several non-respiratory complications. Increased susceptibility to COVID-19 hospitalization and mortality have been linked to associated comorbidities as diabetes, hypertension, cardiovascular diseases and, recently, to obesity. Similarly, individuals living with obesity are at greater risk to develop clinical complications and to have poor prognosis in severe influenza pneumonia. Immune and metabolic dysfunctions associated with the increased susceptibility to influenza infection are linked to obesity-associated low-grade inflammation, compromised immune and endocrine systems, and to high cardiovascular risk. These preexisting conditions may favor virological persistence, amplify immunopathological responses and worsen hemodynamic instability in severe COVID-19 as well. In this review we highlight the main factors and the current state of the art on obesity as risk factor for influenza and COVID-19 hospitalization, severe respiratory manifestations, extrapulmonary complications and even death. Finally, immunoregulatory mechanisms of severe influenza pneumonia in individuals with obesity are addressed as likely factors involved in COVID-19 pathophysiology.

22 December 2014 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
MAMariana Macedo de Almeida
Mariana Macedo de Almeida
SLSheila Cristina Potente Dutra Luquetti
Sheila Cristina Potente Dutra Luquetti
CSCéphora Maria Sabarense
Céphora Maria Sabarense
JCJosé Otávio Do Amaral Corrêa
José Otávio Do Amaral Corrêa
LRLarissa Gomes Dos Reis
Larissa Gomes Dos Reis
RGRaúl Marcel González Garcia
Raúl Marcel González Garcia
Evidence from in vitro and animal studies indicates that conjugated linoleic acid (CLA) possesses anti-diabetic properties, which appear to be attributed to cis-9, trans-11 CLA, the major CLA isomer in ruminant fat. However, there is a shortage of studies addressing CLA from natural source. The present study aimed to evaluate the effects of butter naturally enriched in cis-9, trans-11 CLA on parameters related to glucose tolerance, insulin sensitivity and dyslipidemia in rats. Forty male Wistar rats were randomly assigned to the following dietary treatments (n = 10/group), for 60 days: 1) Normal fat-Soybean oil (NF-So): diet containing 4.0% soybean oil (SO); 2) High Fat-Control Butter (HF-Cb): diet containing 21.7% control butter and 2.3% SO; 3) High Fat-CLA enriched Butter (HF-CLAb): diet containing 21.7% cis-9, trans-11 CLA-enriched butter and 2.3% SO; and 4) High fat-Soybean oil (HF-So): diet containing 24.0% SO. HF-Cb and HF-CLAb diets contained 0.075% and 0.235% of cis-9, trans-11 CLA, respectively. HF-CLAb-fed rats had lower serum insulin levels at fasting than those fed with the HF-Cb diet, while the PPARγ protein levels in adipose tissue was increased in HF-CLAb-fed rats compared to HF-Cb-fed rats. Furthermore, R-QUICK was lower in HF-Cb than in NF-So group, while no differences in R-QUICK were observed among NF-So, HF-CLAb and HF-So groups. Serum HDL cholesterol levels were higher in HF-CLAb-fed rats than in those fed NF-So, HF-Cb and HF-So diets, as well as higher in NF-So-fed rats than in HF-Cb and HF-So-fed rats. HF-CLAb, HF-Cb and HF-So diets reduced serum LDL cholesterol levels when compared to NF-So, whereas serum triacylglycerol levels were increased in HF-CLAb. Feeding rats on a high-fat diet containing butter naturally enriched in cis-9, trans-11 CLA prevented hyperinsulinemia and increased HDL cholesterol, which could be associated with higher levels of cis-9, trans-11 CLA, vaccenic acid, oleic acid and lower levels of short and medium-chain saturated fatty acids from butter naturally modified compared to control butter. On the other hand CLA-enriched butter also increased serum triacylglycerol levels, which could be associated with concomitant increases in the content of trans-9 and trans-10 C18:1 isomers in the CLA-enriched butter.

1 October 2011 in Immunobiology
Verified
Journal Article
Closed access
CRCarolina Francelin Rovarotto
Carolina Francelin Rovarotto
LPLuciana Campos Paulino
Luciana Campos Paulino
JGJacy Gameiro
Jacy Gameiro
LVLiana Verinaud
Liana Verinaud

1 February 2012 in International Immunopharmacology
Verified
Journal Article
Closed access
SCSandra Castro
Sandra Castro
celso de oliveira Rezende Júniorcelso de oliveira Rezende Júnior
celso de oliveira Rezende Júnior
Caio Cesar Souza AlvesCaio Cesar Souza Alves
Caio Cesar Souza Alves
ADAlyria T. Dias
Alyria T. Dias
LALívia L. Alves
Lívia L. Alves
AFAna Paula Ferreira
Ana Paula Ferreira